180 Life Sciences (ATNF) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free ATNF Stock Alerts $2.02 +0.09 (+4.66%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 14, 2024 | finanznachrichten.de180 Life Sciences Corp.: 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | finance.yahoo.com180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | globenewswire.com180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementFebruary 28, 2024 | marketbeat.comTrading was temporarily halted for "ATNF" at 07:02 PM with a stated reason of "News pending."February 26, 2024 | markets.businessinsider.com180 Life Sciences Announces 1-For 19 Reverse Stock Split - Quick FactsFebruary 26, 2024 | globenewswire.com180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanFebruary 17, 2024 | thestreet.com180 Life Sciences Corp.December 20, 2023 | benzinga.com180 Life Sciences Stock (NASDAQ:ATNF), Quotes and News SummaryDecember 4, 2023 | marketwatch.com180 Life Sciences Hires Financial Adviser to Help Explore Strategic AlternativesDecember 4, 2023 | finance.yahoo.com180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesNovember 28, 2023 | finanznachrichten.de180 Life Sciences Corp.: 180 Life Sciences Announces Review of Strategic AlternativesNovember 28, 2023 | finance.yahoo.com180 Life Sciences Announces Review of Strategic AlternativesOctober 7, 2023 | nasdaq.com180 Life Sciences Corp. Common Stock (ATNF)September 15, 2023 | benzinga.comInnovative Biotech Company Announces Agreement To Perform CBD Pill Clinical StudyAugust 14, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces Closing of $3 Million Public OfferingAugust 7, 2023 | benzinga.com180 Life Sciences Teams Up With Hadassah Hospital To Test A New Formulation Of CBD For Enhanced Oral UptakeAugust 7, 2023 | finance.yahoo.com180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral UptakeAugust 3, 2023 | finance.yahoo.com180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDAJuly 31, 2023 | benzinga.com180 Life Sciences Files A Provisional Patent For CBD-Based Appetite SuppressantJuly 31, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress AppetiteApril 10, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private PlacementApril 5, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private PlacementApril 5, 2023 | marketbeat.comTrading was temporarily halted for "ATNF" at 01:04 PM with a stated reason of "LULD pause."April 5, 2023 | investorplace.comWhy Is 180 Life Sciences (ATNF) Stock Up 30% Today?February 28, 2023 | finance.yahoo.com180 Life Sciences Announces Presentation at the Gordon ConferenceFebruary 27, 2023 | finance.yahoo.com180 Life Sciences Announces Presentation at the Gordon ConferenceFebruary 23, 2023 | finance.yahoo.com180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and ApplicationFebruary 23, 2023 | seekingalpha.com180 Life Sciences stock dips as recruitment in trial for Frozen shoulder closes amid challengesFebruary 23, 2023 | seekingalpha.com180 Life Sciences to get US patent linked to treating hand disorder DupuytrenFebruary 23, 2023 | finance.yahoo.com180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and ApplicationFebruary 22, 2023 | benzinga.com180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder TrialFebruary 22, 2023 | finance.yahoo.com180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder TrialFebruary 2, 2023 | marketbeat.comTrading was temporarily halted for "ATNF" at 01:02 PM with a stated reason of "LULD pause."January 25, 2023 | finance.yahoo.com180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s DiseaseJanuary 25, 2023 | msn.com180 Life Sciences up 12% on tumor necrosis factor as target for Dupuytren’s diseaseJanuary 25, 2023 | finance.yahoo.com180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s DiseaseJanuary 17, 2023 | finance.yahoo.com180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United KingdomJanuary 10, 2023 | wsj.comNewman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)January 5, 2023 | finance.yahoo.com180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementJanuary 4, 2023 | au.finance.yahoo.com180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren’s DiseaseJanuary 4, 2023 | finance.yahoo.com180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren’s DiseaseJanuary 3, 2023 | benzinga.comThinking about buying stock in Mullen Automotive, SWVL Holdings, 180 Life Sciences, Alibaba, or Pinterest?December 23, 2022 | finance.yahoo.com180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesDecember 20, 2022 | msn.comWhat's Going On With 180 Life Sciences Shares?December 20, 2022 | benzinga.com180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesDecember 20, 2022 | finance.yahoo.com180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesDecember 20, 2022 | marketbeat.comTrading was temporarily halted for "ATNF" at 02:12 PM with a stated reason of "LULD pause."December 20, 2022 | marketbeat.comTrading was temporarily halted for "ATNF" at 10:12 AM with a stated reason of "LULD pause."December 20, 2022 | marketbeat.comTrading was temporarily halted for "ATNF" at 10:12 AM with a stated reason of "LULD pause."December 19, 2022 | marketbeat.comTrading was temporarily halted for "ATNF" at 01:12 PM with a stated reason of "LULD pause." Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. ATNF Media Mentions By Week ATNF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATNF News Sentiment▼0.910.57▲Average Medical News Sentiment ATNF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATNF Articles This Week▼30▲ATNF Articles Average Week Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PRFX News Today ALLR News Today INM News Today QLGN News Today PXMD News Today NBSE News Today CMND News Today BPTH News Today GLMD News Today LSDI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATNF) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry ResearchNot Trump. Not Biden. But ___________.The Freeport SocietyThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
